Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

10/11/2026

Chiarimenti sull’utilizzo delle fonti bibliografiche dei materiali promozionali dei medicinali

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

03/11/2026

Newsletter Promozione della Salute – Dors, novembre 2026

Agendas and minutes

10/11/2026

Agenda - Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection

Consumer Updates RSS Feed

21/10/2026

Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms

Regulatory and procedural guidelines (human and veterinary)

09/11/2026

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026

Scientific guidelines (human and veterinary)

09/11/2026

Draft guideline on risk assessment of medicinal products in human reproduction and breastfeeding: from data to product information - Revision 1

Paediatric investigation plans

04/11/2026

EMA/PE/0000257220

Orphan designations

10/11/2026

Orphan designation: talquetamab Treatment of multiple myeloma, 20/08/2021 Withdrawn

New medicines and opinions: human

16/10/2026

Human medicines European public assessment report (EPAR): Fovlussea, ranibizumab, Ophthalmologicals, Status: Opinion

MedWatch Safety Alerts RSS Feed

10/11/2026

Early Alert: Arrow International Removes Products Containing Spring Wire Guide Components

What's New: Drugs RSS Feed

10/11/2026

FDA approves pimicotinib for symptomatic tenosynovial giant cell tumor

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis